Infection toxicity assessment of tumor necrosis factor α inhibitors in the treatment of IBD: a real-world study based on the US food and drug administration adverse events reporting system (FAERS)
Compared with other control therapies, TNF-α inhibitors have the strongest infectious toxicity signal. Compared with other TNF-α inhibitors, golimumab has the strongest infectious toxicity signal. When using TNF-α inhibitors to treat IBD, infection-related AEs should be vigilant.
Authors
- Mengling Ouyang (ORCID: https://orcid.org/0009-0002-5244-8379)
- Yazheng Zhao (ORCID: https://orcid.org/0000-0002-5162-4812)
- Shupeng Zou (ORCID: https://orcid.org/0000-0003-3545-5411)
- Qian Cheng (ORCID: https://orcid.org/0000-0003-4362-5783)
- Zeyu Yao (ORCID: https://orcid.org/0009-0004-5349-9041)
- Minghui Sun (ORCID: https://orcid.org/0000-0002-1556-543X)
- Xuan Shi (ORCID: https://orcid.org/0000-0002-6226-8833)
Institutions
- Tongji Hospital (CN)
- Huazhong University of Science and Technology (CN)
Publication Details
- Journal
- Expert Opinion on Drug Safety
- Published
- 2025-03-29
- DOI
- https://doi.org/10.1080/14740338.2025.2486309
- Citations
- 2
- Primary Topic
- Inflammatory Bowel Disease
- Type
- article
- Field-Weighted Citation Impact
- 3.63